The observed differences in correlations of the DNA methylation of these with SFA- and NASH-related CpGs with fasting plasma glucose and serum insulin levels may reveal specific mechanisms related to NASH-linked clinical phenotypes. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.